Page last updated: 2024-08-22

trimetazidine and Coronary Artery Vasospasm

trimetazidine has been researched along with Coronary Artery Vasospasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byun, JK; Choi, BG; Choi, CU; Choi, JY; Choi, SY; Her, AY; Jang, WY; Kim, EJ; Kim, W; Kim, YH; Lim, HE; Mashaly, A; Na, JO; Oh, DJ; Park, CG; Park, EJ; Park, Y; Rha, SW; Seo, HS1

Other Studies

1 other study(ies) available for trimetazidine and Coronary Artery Vasospasm

ArticleYear
Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018, Volume: 18, Issue:2

    Topics: Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Female; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Spasm; Treatment Outcome; Trimetazidine; Vasodilator Agents

2018